CARGO Therapeutics, Inc. (CRGX)
(Delayed Data from NSDQ)
$22.36 USD
+0.87 (4.05%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $22.32 -0.04 (-0.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth D Momentum D VGM
Price, Consensus and EPS Surprise
CRGX 22.36 +0.87(4.05%)
Will CRGX be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CRGX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRGX
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
CRGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Company News for Mar 25, 2024
Alexandria (ARE) to Post Q4 Earnings: What's in the Cards?
Alexandria (ARE) Inks Leases at its Campuses Amid Solid Demand
Other News for CRGX
Piper Sandler Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)
Cargo Therapeutics announces ASH 2024 abstract on CRG-023
Cargo Therapeutics announces ASH 2024 abstract on CRG-023
Firi-cel’s Promising Outlook and Undervalued Potential Drive Buy Rating for CARGO Therapeutics
CRGX Stock Earnings: Cargo Therapeutics Beats EPS for Q2 2024